25 February 2015
NPS MEDICINEWISE BOARD APPOINTS NEW CHAIR
NPS MedicineWise is very pleased to announce the appointment of Mr Peter Turner as the new Chair of the NPSMedicineWise Board. Mr Turner has served on the NPS MedicineWise Board since December 2012, and is the fourth chair since the organisation commenced in 1998.
Mr Turner took over from outgoing chair and general practitioner, Dr Janette Randall, in January 2015. Dr Randall will continue as a director of NPS MedicineWise until her term ends in May 2015.
Dr Randall welcomed the appointment of Mr Turner, saying, “The NPS MedicineWise Board is very pleased that Peter Turner has accepted the role of chair. He brings a wealth of domestic and international experience in the biopharmaceutical sector and is well placed to lead NPS MedicineWise into the future as the organisation strives to build a medicinewise Australia.”
Mr Turner has over 40 years’ experience in the biopharmaceutical industry, and previously served as executive director and chief operating officer of CSL Limited. His expertise includes international healthcare, managing global business expansion, blood plasma therapies, protein separation technologies, pharmaceutical product development and quality assurance and industrial scale biotechnology. Peter is a past chairman and board member of the PPTA (Plasma Protein Therapeutics Association) and is a current non executive director of Virtus Health Limited and a graduate member of the Australian Institute of Company Directors.
Mr Turner says he is honored to take on the role of chair of NPS MedicineWise and looks forward to his continuing involvement with NPS MedicineWise.
“NPS MedicineWise has a crucial role as a source of quality, evidence-based information for health professionals and the broader community. We live in a world with a lot of noise about medicine and technology—the work of NPS MedicineWise is extremely important in supporting wise health choices and helping people achieve better health outcomes.”
NPS MedicineWise CEO Dr Lynn Weekes thanked Dr Randall for her leadership throughout a period of considerable change and growth from 2007 to 2015.
“Dr Randall has been an excellent chair and absolutely instrumental in guiding the strategic direction of the organisation. I thank her for her leadership, insight and passion, and am delighted that she has indicated she will continue to be involved in the work of NPS MedicineWise,” said Dr Weekes.